Getting Vitamin D Dosing Right

Status Completed

Clinical Trial Summary

The investigators want to make sure that people get the right dose of Vitamin D treatment. They will therefore investigate how skin colour, body mass index, ethnicity, vitamin D binding protein and genetic variation affect the response to a standard course of vitamin D in young adults, as a prelude to further studies in younger children.

Clinical Trial Description

The Department of Health and the Chief Medical Officer have identified vitamin D deficiency as a key area of interest and concern for public health.

The main function of vitamin D is to enable dietary calcium to be absorbed from the intestine. Low levels of vitamin D can lead to diseases of bone such as rickets and osteomalacia and are linked to a higher risk of fracturing bones in older women with osteoporosis.

Vitamin D levels may be affected by the skin colour, body mass index (BMI), lifestyle or environment in which someone lives, and by their genetic makeup. Vitamin D levels tend to be lower in people with higher BMI and / or darker coloured skin or if the skin is covered by clothing because a lot of vitamin D is made from the action of sunlight on natural chemicals in the skin.

Vitamin D does occur naturally in the diet in foods like oily fish, and also vitamin D can be given as a supplement either on its own or as part of a multivitamin tablet.

There is natural variation from one person to another in how well the system controlling vitamin D blood levels works. Vitamin D circulates bound to a carrier protein, vitamin D binding protein (VDBP). When vitamin D levels are measured, both vitamin D bound to the protein and "free" vitamin D are measured.

A recent study in America showed that when "free" vitamin D levels (total vitamin D minus vitamin D bound to VDBP) are measured, they correlate very closely with other factors that help determine blood calcium levels.This variation is determined in part by a person's genetic makeup, and recent large studies have identified specific genetic variations that are linked to blood levels of vitamin D; some of these vary with the person's ethnic origin.

At present if someone has low vitamin D levels that put them at increased risk of bone problems, a course of vitamin D treatment is given.

When the investigators assessed their regular treatment given to children recently, they found some individuals developed very high blood vitamin D levels and others didn't.

They don't know how VDBP levels affect the response to treatment with vitamin D.

Further variation can occur because of the distribution of vitamin D into fat tissue. The investigators will measure height and weight, and waist and hip circumference and calculate Body Mass Index, body surface area (BSA) and waist: hip ratio as proxy measures of fat mass.

They will also evaluate whether blood or saliva tests give better information about vitamin D levels. The information about how these factors affect the response to vitamin D will help the clinicians choose the right dose of vitamin D for studies in younger children who are still growing. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Vitamin D Status

Clinical Trial Details

NCT number	NCT02474446
Study type	Interventional
Source	Sheffield Children's NHS Foundation Trust
Contact
Status	Completed
Phase	N/A
Start date	December 2014
Completion date	February 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02822651` - Hypovitaminosis D Prediction Score	N/A
Completed	`NCT01825616` - Vitamin D2, Muscle Damage, NASCAR Pitcrew	N/A
Completed	`NCT01101243` - Maintenance of Vitamin D Level by UVB Radiation	N/A
Completed	`NCT00650780` - Vitamin D Binding Protein (Gc) Allele Variation Effects Response to Vitamin D Treatment	N/A
Active, not recruiting	`NCT01798030` - Vitamin D Retrospective Study and Role With Disease
Completed	`NCT00864539` - Comparison of the Efficacy of Calcium-cholecalciferol Foodstuffs and Calcium-cholecalciferol Supplement	Phase 2/Phase 3
Suspended	`NCT04399291` - Vitamin D Status and Bone Health of Older Adults in Care Facilities
Completed	`NCT00818467` - UVB Light and Sunscreen	Phase 4
Completed	`NCT05931705` - Vit D Receptor Gene Polymorphism
Recruiting	`NCT03132103` - Vitamin D Supplementation and Immunity/Physical Performance	N/A
Completed	`NCT01723852` - Vitamin D Intervention in Infants	N/A
Completed	`NCT01074541` - The Vitamin D Dose-Response Relationship	N/A
Completed	`NCT01042197` - The Relation Between Vitamin D Production and UVB Exposed Body Surface Area	N/A
Completed	`NCT02858882` - Vitamin D Status and Muscle Function	N/A
Recruiting	`NCT06241976` - Diabetes Risk in East London and Its Association With Vitamin D by Ethnic Group (DELVE)	N/A
Completed	`NCT02608164` - A Comparison of Capsules and Oral Spray Solution as Methods of Delivering Vitamin D3 and Raising Status	N/A
Completed	`NCT02860663` - Effect of Different Vitamin D Vitamers on Vitamin D Status	N/A
Completed	`NCT01348594` - The Impact of Vitamin D Status on in Vitro Fertilization (IVF) Outcomes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.